JIA Hai-yong, YU Ji, LIU Xin-hao, ZHANG Jian, ZHAN Peng, LIU Xin-yong. Recent progress of inhibitors targeting HIV-1 NCp7J. Acta Pharmaceutica Sinica, 2017,52(11): 1652-1659. doi: 10.16438/j.0513-4870.2017-0460
Citation: JIA Hai-yong, YU Ji, LIU Xin-hao, ZHANG Jian, ZHAN Peng, LIU Xin-yong. Recent progress of inhibitors targeting HIV-1 NCp7J. Acta Pharmaceutica Sinica, 2017,52(11): 1652-1659. doi: 10.16438/j.0513-4870.2017-0460

Recent progress of inhibitors targeting HIV-1 NCp7

  • The acquired immunodeficiency syndrome (AIDS) is a serious infectious disease infected by human immunodeficiency virus type 1 (HIV-1). HIV-1 nucleocapsid protein 7 (HIV-1 NCp7) plays an important role in the progress of virus reverse transcription and integration. Thus, the central role and conservative nature of the NCp7 protein make it an attractive target for development of novel anti-HIV agents. This review summarizes the research progress of HIV-1 NCp7 inhibitors in the past decade.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return